Does the media prefer BBNX or MBOT?

In the previous week, Beta Bionics had 9 more articles in the media than Microbot Medical. MarketBeat recorded 11 mentions for Beta Bionics and 2 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 0.93 beat Beta Bionics' score of 0.08 indicating that Microbot Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Beta Bionics 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Microbot Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to MBOT or KIDS?

In the previous week, OrthoPediatrics had 1 more articles in the media than Microbot Medical. MarketBeat recorded 3 mentions for OrthoPediatrics and 2 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 0.93 beat OrthoPediatrics' score of 0.63 indicating that Microbot Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Microbot Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive OrthoPediatrics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts recommend CNXU or MBOT?

Microbot Medical has a consensus target price of $6.63, suggesting a potential upside of 274.29%. Given Microbot Medical's stronger consensus rating and higher possible upside, analysts clearly believe Microbot Medical is more favorable than Conexeu Sciences. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Conexeu Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Microbot Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.60

Which has preferable earnings & valuation, CNXU or MBOT?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Conexeu Sciences N/A N/A N/A N/A N/A Microbot Medical N/A N/A -$13.14M -$0.26 N/A

Is CNXU or MBOT more profitable?

Conexeu Sciences' return on equity of 0.00% beat Microbot Medical's return on equity. Company Net Margins Return on Equity Return on Assets Conexeu Sciences N/A N/A N/A Microbot Medical N/A -21.84% -20.71%

Does the media prefer CNXU or MBOT?

In the previous week, Conexeu Sciences had 3 more articles in the media than Microbot Medical. MarketBeat recorded 5 mentions for Conexeu Sciences and 2 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 0.93 beat Conexeu Sciences' score of 0.55 indicating that Microbot Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Conexeu Sciences 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Microbot Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Microbot Medical (MBOT) Competitors

$1.77 -0.05 (-2.75%)

Closing price 04:00 PM Eastern

Extended Trading

$1.78 +0.01 (+0.79%)

As of 07:16 PM Eastern

Compare

MBOT vs. BBNX, KIDS, CLPT, DCTH, and CNXU

Should you buy Microbot Medical stock or one of its competitors? MarketBeat compares Microbot Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Microbot Medical include Beta Bionics (BBNX), OrthoPediatrics (KIDS), ClearPoint Neuro (CLPT), Delcath Systems (DCTH), and Conexeu Sciences (CNXU). These companies are all part of the "medical equipment" industry.

How does Microbot Medical compare to Beta Bionics?

Beta Bionics (NASDAQ:BBNX) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, valuation, institutional ownership, profitability, risk and analyst recommendations.

In the previous week, Beta Bionics had 9 more articles in the media than Microbot Medical. MarketBeat recorded 11 mentions for Beta Bionics and 2 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 0.93 beat Beta Bionics' score of 0.08 indicating that Microbot Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Beta Bionics	2 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Microbot Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

16.3% of Microbot Medical shares are held by institutional investors. 5.3% of Beta Bionics shares are held by insiders. Comparatively, 4.7% of Microbot Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Beta Bionics has a beta of 3.4, suggesting that its share price is 240% more volatile than the broader market. Comparatively, Microbot Medical has a beta of 1.04, suggesting that its share price is 4% more volatile than the broader market.

Beta Bionics currently has a consensus price target of $19.70, indicating a potential upside of 43.59%. Microbot Medical has a consensus price target of $6.63, indicating a potential upside of 274.29%. Given Microbot Medical's higher probable upside, analysts plainly believe Microbot Medical is more favorable than Beta Bionics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Beta Bionics	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

Microbot Medical has lower revenue, but higher earnings than Beta Bionics. Beta Bionics is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Beta Bionics	$100.25M	6.10	-$73.20M	-$1.51	N/A
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A

Microbot Medical has a net margin of 0.00% compared to Beta Bionics' net margin of -60.27%. Microbot Medical's return on equity of -21.84% beat Beta Bionics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Beta Bionics	-60.27%	-23.00%	-20.55%
Microbot Medical	N/A	-21.84%	-20.71%

Summary

Microbot Medical beats Beta Bionics on 8 of the 15 factors compared between the two stocks.

How does Microbot Medical compare to OrthoPediatrics?

Microbot Medical (NASDAQ:MBOT) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, analyst recommendations, risk, valuation, institutional ownership, earnings and media sentiment.

16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 69.1% of OrthoPediatrics shares are held by institutional investors. 4.7% of Microbot Medical shares are held by insiders. Comparatively, 31.8% of OrthoPediatrics shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Microbot Medical has a net margin of 0.00% compared to OrthoPediatrics' net margin of -16.31%. OrthoPediatrics' return on equity of -7.01% beat Microbot Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbot Medical	N/A	-21.84%	-20.71%
OrthoPediatrics	-16.31%	-7.01%	-4.86%

In the previous week, OrthoPediatrics had 1 more articles in the media than Microbot Medical. MarketBeat recorded 3 mentions for OrthoPediatrics and 2 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 0.93 beat OrthoPediatrics' score of 0.63 indicating that Microbot Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Microbot Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
OrthoPediatrics	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Microbot Medical has higher earnings, but lower revenue than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A
OrthoPediatrics	$236.35M	2.01	-$39.65M	-$1.68	N/A

Microbot Medical currently has a consensus target price of $6.63, indicating a potential upside of 274.29%. OrthoPediatrics has a consensus target price of $24.44, indicating a potential upside of 32.42%. Given Microbot Medical's higher possible upside, research analysts plainly believe Microbot Medical is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82

Microbot Medical has a beta of 1.04, meaning that its stock price is 4% more volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 1.03, meaning that its stock price is 3% more volatile than the broader market.

Summary

OrthoPediatrics beats Microbot Medical on 8 of the 15 factors compared between the two stocks.

How does Microbot Medical compare to ClearPoint Neuro?

Microbot Medical (NASDAQ:MBOT) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, analyst recommendations, media sentiment, dividends, profitability and risk.

Microbot Medical currently has a consensus price target of $6.63, suggesting a potential upside of 274.29%. ClearPoint Neuro has a consensus price target of $18.00, suggesting a potential upside of 30.91%. Given Microbot Medical's stronger consensus rating and higher possible upside, research analysts clearly believe Microbot Medical is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Microbot Medical has a beta of 1.04, indicating that its stock price is 4% more volatile than the broader market. Comparatively, ClearPoint Neuro has a beta of 1.31, indicating that its stock price is 31% more volatile than the broader market.

Microbot Medical has higher earnings, but lower revenue than ClearPoint Neuro. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Microbot Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A
ClearPoint Neuro	$36.97M	11.15	-$25.54M	-$1.01	N/A

Microbot Medical has a net margin of 0.00% compared to ClearPoint Neuro's net margin of -71.57%. Microbot Medical's return on equity of -21.84% beat ClearPoint Neuro's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbot Medical	N/A	-21.84%	-20.71%
ClearPoint Neuro	-71.57%	-140.96%	-36.98%

In the previous week, Microbot Medical had 1 more articles in the media than ClearPoint Neuro. MarketBeat recorded 2 mentions for Microbot Medical and 1 mentions for ClearPoint Neuro. ClearPoint Neuro's average media sentiment score of 1.86 beat Microbot Medical's score of 0.93 indicating that ClearPoint Neuro is being referred to more favorably in the news media.

Company	Overall Sentiment
Microbot Medical	Positive
ClearPoint Neuro	Very Positive

16.3% of Microbot Medical shares are held by institutional investors. Comparatively, 30.1% of ClearPoint Neuro shares are held by institutional investors. 4.7% of Microbot Medical shares are held by company insiders. Comparatively, 6.9% of ClearPoint Neuro shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Microbot Medical beats ClearPoint Neuro on 10 of the 15 factors compared between the two stocks.

How does Microbot Medical compare to Delcath Systems?

Microbot Medical (NASDAQ:MBOT) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, media sentiment, dividends, analyst recommendations, valuation, risk and profitability.

Microbot Medical has a beta of 1.04, indicating that its stock price is 4% more volatile than the broader market. Comparatively, Delcath Systems has a beta of 0.54, indicating that its stock price is 46% less volatile than the broader market.

Delcath Systems has higher revenue and earnings than Microbot Medical. Microbot Medical is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A
Delcath Systems	$85.23M	4.53	$2.70M	$0.01	1,119.00

Delcath Systems has a net margin of 0.62% compared to Microbot Medical's net margin of 0.00%. Delcath Systems' return on equity of 0.51% beat Microbot Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Microbot Medical	N/A	-21.84%	-20.71%
Delcath Systems	0.62%	0.51%	0.46%

In the previous week, Microbot Medical had 1 more articles in the media than Delcath Systems. MarketBeat recorded 2 mentions for Microbot Medical and 1 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 1.89 beat Microbot Medical's score of 0.93 indicating that Delcath Systems is being referred to more favorably in the news media.

Company	Overall Sentiment
Microbot Medical	Positive
Delcath Systems	Very Positive

16.3% of Microbot Medical shares are owned by institutional investors. Comparatively, 61.1% of Delcath Systems shares are owned by institutional investors. 4.7% of Microbot Medical shares are owned by insiders. Comparatively, 19.4% of Delcath Systems shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Microbot Medical currently has a consensus target price of $6.63, suggesting a potential upside of 274.29%. Delcath Systems has a consensus target price of $22.50, suggesting a potential upside of 101.07%. Given Microbot Medical's stronger consensus rating and higher probable upside, analysts plainly believe Microbot Medical is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
Delcath Systems	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.43

Summary

Delcath Systems beats Microbot Medical on 11 of the 16 factors compared between the two stocks.

How does Microbot Medical compare to Conexeu Sciences?

Conexeu Sciences (NASDAQ:CNXU) and Microbot Medical (NASDAQ:MBOT) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, risk, analyst recommendations, earnings, dividends and institutional ownership.

In the previous week, Conexeu Sciences had 3 more articles in the media than Microbot Medical. MarketBeat recorded 5 mentions for Conexeu Sciences and 2 mentions for Microbot Medical. Microbot Medical's average media sentiment score of 0.93 beat Conexeu Sciences' score of 0.55 indicating that Microbot Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Conexeu Sciences	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Microbot Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Conexeu Sciences' return on equity of 0.00% beat Microbot Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Conexeu Sciences	N/A	N/A	N/A
Microbot Medical	N/A	-21.84%	-20.71%

Microbot Medical has a consensus target price of $6.63, suggesting a potential upside of 274.29%. Given Microbot Medical's stronger consensus rating and higher possible upside, analysts clearly believe Microbot Medical is more favorable than Conexeu Sciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Conexeu Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Microbot Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60

16.3% of Microbot Medical shares are held by institutional investors. 4.7% of Microbot Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Conexeu Sciences	N/A	N/A	N/A	N/A	N/A
Microbot Medical	N/A	N/A	-$13.14M	-$0.26	N/A

Summary

Microbot Medical beats Conexeu Sciences on 7 of the 10 factors compared between the two stocks.

Get Microbot Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MBOT vs. The Competition

Export

Metric	Microbot Medical	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$118.89M	$7.10B	$6.43B	$11.71B
Dividend Yield	N/A	1.20%	2.67%	5.55%
P/E Ratio	-6.81	46.97	24.46	23.62
Price / Sales	N/A	73.08	500.50	105.27
Price / Cash	N/A	24.77	42.36	56.09
Price / Book	1.54	6.93	10.43	6.70
Net Income	-$13.14M	$159.22M	$3.56B	$337.26M
7 Day Performance	-10.15%	-1.91%	-1.39%	-1.41%
1 Month Performance	-16.90%	3.26%	0.86%	1.15%
1 Year Performance	-31.92%	-2.82%	19.42%	22.61%

Microbot Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MBOT Microbot Medical	2.6356 of 5 stars	$1.77 -2.7%	$6.63 +274.3%	-26.9%	$118.89M	N/A	N/A	20
BBNX Beta Bionics	3.2788 of 5 stars	$12.80 +5.6%	$19.70 +53.9%	-25.9%	$540.09M	$100.25M	N/A	294
KIDS OrthoPediatrics	2.9727 of 5 stars	$16.65 -3.0%	$24.44 +46.8%	-14.2%	$441.01M	$243.30M	N/A	200	Positive News
CLPT ClearPoint Neuro	2.3641 of 5 stars	$12.64 -0.2%	$18.00 +42.4%	+2.1%	$379.97M	$36.97M	N/A	110	Analyst Forecast
DCTH Delcath Systems	3.1261 of 5 stars	$10.60 -1.7%	$22.50 +112.3%	-26.7%	$372.14M	$85.23M	1,060.00	60	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MBOT) was last updated on 6/10/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Microbot Medical (MBOT) Competitors

MBOT vs. BBNX, KIDS, CLPT, DCTH, and CNXU

How does Microbot Medical compare to Beta Bionics?

Summary

How does Microbot Medical compare to OrthoPediatrics?

Summary

How does Microbot Medical compare to ClearPoint Neuro?

Summary

How does Microbot Medical compare to Delcath Systems?

Summary

How does Microbot Medical compare to Conexeu Sciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MBOT vs. The Competition

Microbot Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Microbot Medical (MBOT) Competitors

MBOT vs. BBNX, KIDS, CLPT, DCTH, and CNXU

How does Microbot Medical compare to Beta Bionics?

Does the media prefer BBNX or MBOT?

Do insiders & institutionals hold more shares of BBNX or MBOT?

Which has more volatility & risk, BBNX or MBOT?

Do analysts rate BBNX or MBOT?

Which has stronger valuation and earnings, BBNX or MBOT?

Is BBNX or MBOT more profitable?

Summary

How does Microbot Medical compare to OrthoPediatrics?

Do institutionals and insiders believe in MBOT or KIDS?

Is MBOT or KIDS more profitable?

Does the media refer more to MBOT or KIDS?

Which has higher valuation & earnings, MBOT or KIDS?

Do analysts rate MBOT or KIDS?

Which has more risk and volatility, MBOT or KIDS?

Summary

How does Microbot Medical compare to ClearPoint Neuro?

Do analysts prefer MBOT or CLPT?

Which has more risk and volatility, MBOT or CLPT?

Which has preferable earnings and valuation, MBOT or CLPT?

Is MBOT or CLPT more profitable?

Does the media refer more to MBOT or CLPT?

Do insiders & institutionals have more ownership in MBOT or CLPT?

Summary

How does Microbot Medical compare to Delcath Systems?

Which has more risk & volatility, MBOT or DCTH?

Which has stronger earnings & valuation, MBOT or DCTH?

Is MBOT or DCTH more profitable?

Does the media refer more to MBOT or DCTH?

Do institutionals and insiders have more ownership in MBOT or DCTH?

Do analysts prefer MBOT or DCTH?

Summary

How does Microbot Medical compare to Conexeu Sciences?

Does the media prefer CNXU or MBOT?

Is CNXU or MBOT more profitable?

Do analysts recommend CNXU or MBOT?

Do institutionals and insiders hold more shares of CNXU or MBOT?

Which has preferable earnings & valuation, CNXU or MBOT?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MBOT vs. The Competition

Microbot Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools